لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Vinayak S; University of Washington, Division of Oncology, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: shaveta@uw.edu., Cecil DL; University of Washington, Division of Oncology, Seattle, WA, USA., Disis ML; University of Washington, Division of Oncology, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.

المصدر: Molecular aspects of medicine [Mol Aspects Med] 2024 Aug; Vol. 98, pp. 101292. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 7603128 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9452 (Electronic) Linking ISSN: 00982997 NLM ISO Abbreviation: Mol Aspects Med Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/prevention & control , Breast Neoplasms*/immunology , Cancer Vaccines*/immunology , Cancer Vaccines*/therapeutic use, Female ; Humans

المؤلفون: Cecil DL; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA. dcecil@uw.edu., Curtis B; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA., Gad E; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA., Gormley M; Janssen Research and Development LLC, Spring House, PA, USA., Timms AE; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA., Corulli L; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA., Bos R; Janssen Vaccines and Prevention, Leiden, The Netherlands., Damle RN; Janssen Research and Development LLC, Spring House, PA, USA., Sepulveda MA; Janssen Research and Development LLC, Spring House, PA, USA., Disis ML; Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA, 98195-8050, USA.

المصدر: Scientific reports [Sci Rep] 2022 Aug 10; Vol. 12 (1), pp. 13618. Date of Electronic Publication: 2022 Aug 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines* , Prostatic Neoplasms*/therapy, Animals ; Antigens ; Disease Models, Animal ; Epitopes ; Epitopes, T-Lymphocyte ; Humans ; Male ; Mice ; T-Lymphocytes

المؤلفون: Cecil DL; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Gad EA; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Corulli LR; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Drovetto N; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Lubet RA; NCI, Bethesda, Maryland., Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2022 Apr 01; Vol. 15 (4), pp. 225-231.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/metabolism , Colonic Neoplasms*/prevention & control , Lymphocytes, Tumor-Infiltrating*, Animals ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes ; Cyclooxygenase 2 Inhibitors/pharmacology ; Mice

المؤلفون: Disis ML; Cancer Vaccine Institute, University of Washington, Seattle, WA, USA. ndisis@uw.edu., Cecil DL; Cancer Vaccine Institute, University of Washington, Seattle, WA, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Feb; Vol. 191 (3), pp. 481-489. Date of Electronic Publication: 2021 Nov 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/prevention & control , Cancer Vaccines*, Clinical Trials, Phase II as Topic ; Epitopes ; Female ; Humans ; Neoplasm Recurrence, Local ; Randomized Controlled Trials as Topic ; T-Lymphocytes

المؤلفون: Cecil DL; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Liao JB; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Dang Y; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Coveler AL; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Kask A; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Yang Y; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Childs JS; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Higgins DM; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington. ndisis@uw.edu.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Dec 01; Vol. 27 (23), pp. 6405-6412. Date of Electronic Publication: 2021 Sep 15.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines* , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/metabolism , Ovarian Neoplasms*/therapy , Vaccines, DNA*, CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Female ; Humans ; Immunization ; Insulin-Like Growth Factor Binding Protein 2/genetics ; Insulin-Like Growth Factor Binding Protein 2/metabolism ; Lymphocyte Activation ; Plasmids/genetics ; Vaccination

المؤلفون: Corulli LR; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Cecil DL; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Gad E; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Koehnlein M; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Coveler AL; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Childs JS; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States., Lubet RA; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Disis ML; University of Washington (UW) Medicine, Cancer Vaccine Institute, University of Washington, Seattle, WA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2021 Aug 30; Vol. 12, pp. 729809. Date of Electronic Publication: 2021 Aug 30 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Epitopes*, Antigens, Neoplasm/*pharmacology , Cancer Vaccines/*pharmacology , Colorectal Neoplasms/*drug therapy , Cyclooxygenase 2/*pharmacology , cdc25 Phosphatases/*pharmacology, Adult ; Aged ; Aged, 80 and over ; Animals ; Antigens, Neoplasm/immunology ; Autoantibodies/blood ; Cancer Vaccines/immunology ; Colorectal Neoplasms/blood ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/immunology ; Cyclooxygenase 2/immunology ; Female ; Genes, APC ; Humans ; Immunity, Humoral ; Immunogenicity, Vaccine ; Immunoglobulin G/blood ; Male ; Mice, Inbred C57BL ; Mice, Transgenic ; Middle Aged ; Vaccination ; Young Adult ; cdc25 Phosphatases/immunology ; Mice

المؤلفون: Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington. ndisis@uw.edu., Corulli LR; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Gad EA; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Koehnlein MR; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Cecil DL; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., Senter PD; Seattle Genetics Inc., Bothell, Washington., Gardai SJ; Seattle Genetics Inc., Bothell, Washington., Okeley NM; Seattle Genetics Inc., Bothell, Washington.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2020 May; Vol. 19 (5), pp. 1102-1109. Date of Electronic Publication: 2020 Mar 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibody-Dependent Cell Cytotoxicity/*drug effects , Fucose/*pharmacology , Mammary Neoplasms, Experimental/*drug therapy , Protein Processing, Post-Translational/*drug effects, Animals ; Apoptosis ; Cell Proliferation ; Female ; Fucose/administration & dosage ; Glycosylation ; Humans ; Mammary Neoplasms, Experimental/immunology ; Mammary Neoplasms, Experimental/pathology ; Mice ; Mice, Transgenic ; Tumor Cells, Cultured

المؤلفون: Cecil DL; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington. dcecil@uw.edu., Slota M; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., O'Meara MM; Seattle Genetics, Inc., Bothell, Washington., Curtis BC; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., Gad E; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., Dang Y; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., Herendeen D; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., Rastetter L; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington., Disis ML; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jul 01; Vol. 23 (13), pp. 3396-3404. Date of Electronic Publication: 2016 Dec 30.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*administration & dosage , Hypoxia-Inducible Factor 1, alpha Subunit/*immunology , Mammary Neoplasms, Animal/*therapy , Triple Negative Breast Neoplasms/*therapy, Animals ; Cancer Vaccines/immunology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/blood ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Immunization ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Mammary Neoplasms, Animal/blood ; Mammary Neoplasms, Animal/immunology ; Mammary Neoplasms, Animal/pathology ; Mice ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/therapy ; Neoplastic Stem Cells/immunology ; Triple Negative Breast Neoplasms/blood ; Triple Negative Breast Neoplasms/immunology ; Triple Negative Breast Neoplasms/pathology